FibroGen (NASDAQ:FGEN) will release its quarterly earnings report on Monday, 2025-08-11. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate FibroGen to report an earnings per share (EPS) of $-0.30.
Investors in FibroGen are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
The company's EPS beat by $0.75 in the last quarter, leading to a 2.0% drop in the share price on the following day.
Here's a look at FibroGen's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.50 | -5 | -7.50 | -6.5 |
| EPS Actual | 1.25 | -2 | -4.25 | -4 |
| Price Change % | -2.0% | -22.0% | -14.000000000000002% | 5.0% |
Tracking FibroGen's Stock Performance
Shares of FibroGen were trading at $7.94 as of August 07. Over the last 52-week period, shares are down 9.4%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for FibroGen visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
